ET-1 and cytokines in airway inflammation
Main Authors: | Page Kristen, Finsnes F, Lyberg T, Christensen G, Skjonsberg OH |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2001-04-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://newdesign.respiratory-research.com/paperreports/rr-2001-68524 |
Similar Items
-
Bosentan, a drug used in the treatment of pulmonary hypertension, can prevent development of osteoporosis
by: Duygu Köse, et al.
Published: (2021-07-01) -
Blockade of Endothelin-1 Receptor Type B Ameliorates Glucose Intolerance and Insulin Resistance in a Mouse Model of Obstructive Sleep Apnea
by: Jan Polak, et al.
Published: (2018-05-01) -
Endothelin receptor antagonists
– a brief description of the new class of drugs
by: Agata Kowalczyk, et al.
Published: (2014-01-01) -
Current status of bosentan for treatment of pulmonary hypertension
by: Raja Shahzad, et al.
Published: (2008-01-01) -
Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan
by: S N Avdeev
Published: (2015-09-01)